|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Loss for the year | |||||
| Adjustments to reconcile loss to net cash used in operating activities | |||||
| Depreciation | |||||
| Share-based payments | |||||
| Impairment of exploration and evaluation assets | |||||
| Accretion expense on government loan | |||||
| Fair value gain on government loan | |||||
| Gain on derivative instruments | |||||
| Gain on disposition of assets | |||||
| Interest on lease obligation | |||||
| Other non-cash adjustments | |||||
| Allowance for doubtful accounts | |||||
| Advances receivable and prepaid expenses | |||||
| Due to/from related parties | |||||
| Employee retention allowance | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Acquisition of additional interest in subsidiary | |||||
| Funds received from leasing agreement | |||||
| Funds received from asset held for sale | |||||
| Disposition of capital assets | |||||
| Acquisition of property, plant and equipment | |||||
| Expenditures on exploration and evaluation assets | |||||
| Net cash generated (used) by investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from share issuances, net of issuance costs | |||||
| Loans (repaid) received | |||||
| Due to related parties | |||||
| Principal repayment of lease obligation | |||||
| Net cash (used) generated by financing activities | |||||
| Net increase in cash and cash equivalents during the year | |||||
| Cash and cash equivalents, beginning of the year | |||||
| Cash and cash equivalents, end of the year | |||||
Loading...